mochi compounded tirzepatide Telehealth for Weight Loss, Hair Loss, Skin & More 3 & 6-Month Compounded GLP-1
Description
After 40 weeks, all three doses of Tirzepatide demonstrated superior HbA1c and body weight reductions compared to placebo
The primary goals of the study were to assess the percentage change in body weight and the proportion of participants achieving at least a 5% reduction in body weight from baseline after 76 weeks of treatment
Risk reduction was greatest for colon cancer (16%) and rectal cancer (28%), but rates were similar or lower for all 14 obesity-related cancersnone showed an increase in the GLP-1 agonist group
Its a common experience, and it doesnt mean the medication isnt working
